- Home
- AUPH vs XMTR Comparison
AUPH vs XMTR Comparison
Compare AUPH & XMTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | XMTR |
|---|---|---|
| Founded | 1993 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 2.8B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AUPH | XMTR |
|---|---|---|
| Price | $13.95 | $36.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | $17.25 | ★ $58.60 |
| AVG Volume (30 Days) | 903.8K | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | 26.95 |
| EPS | ★ 2.07 | N/A |
| Revenue | $283,055,000.00 | ★ $686,631,000.00 |
| Revenue This Year | $17.35 | $23.76 |
| Revenue Next Year | $15.66 | $18.38 |
| P/E Ratio | $6.95 | ★ N/A |
| Revenue Growth | 20.38 | ★ 25.87 |
| 52 Week Low | $6.83 | $18.59 |
| 52 Week High | $16.54 | $73.87 |
Technical Indicators
Market Signals| Indicator | AUPH | XMTR |
|---|---|---|
| Relative Strength Index (RSI) | 41.68 | 32.24 |
| Support Level | $13.52 | $30.67 |
| Resistance Level | $15.23 | $47.53 |
| Average True Range (ATR) | 0.57 | 3.95 |
| MACD | 0.00 | -0.48 |
| Stochastic Oscillator | 24.42 | 6.01 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.